StreetInsider.com News Articles

Cuprina gets FDA clearance for first Lucilia cuprina maggot therapy

Mon, 15 Jun 2026 09:00:22 -0400

Cuprina Holdings (NASDAQ: CUPR) received U.S. Food and Drug Administration 510(k) clearance for MEDIFLY Maggots, a medical-grade Lucilia cuprina larvae product used in maggot debridement therapy. The company stated this represents the first U.S. FDA clearance for a maggot debridement product using the Lucilia cuprina species.

The product is cleared for debridement of non-healing necrotic skin and soft tissue wounds, including pressure ulcers, neuropathic foot ulcers, and non-healing traumatic or post-surgical wounds. Medical-grade fly larvae are applied to wounds under healthcare professional supervision to remove dead and infected tissue.

Cuprina now holds U.S. FDA commercial rights to both maggot species used in

Cuprina Receives U.S. FDA 510(k) Clearance for MEDIFLY Maggots — the First U.S. Clearance for a Lucilia cuprina Maggot Debridement Product

Mon, 15 Jun 2026 09:00:00 -0400

SINGAPORE, June 15, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“CUPR” or “the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals sectors, today announced that an indirectly wholly-owned subsidiary of the Company, Cuprina Pte. Ltd. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MEDIFLY Maggots™, its medical-grade Lucilia cuprina larvae used in maggot debridement therapy (MDT). To the Company’s knowledge, MEDIFLY Maggots™ is the first maggot debridement product to receive U.S. FDA 510(k) clearance using the Lucilia cuprina species.

Cuprina Receives U.S. FDA 510(k) Clearance for MEDIFLY Maggots — the First U.S. Clearance for a Lucilia cuprina Maggot Debridement Product

Mon, 15 Jun 2026 09:00:00 -0400

Form 6-K Cuprina Holdings (Cayman For: Jun 15

Mon, 15 Jun 2026 09:00:00 -0400

http://archive.fast-edgar.com/20260615/A32ZB22CZM2RITOZ2K2T2ZY2OPGEZZ22ZL82

Filed on: June 15, 2026

Form 6-K Cuprina Holdings (Cayman For: Jun 15

Mon, 15 Jun 2026 09:00:00 -0400

http://archive.fast-edgar.com/20260615/A32ZB22CZM2RITOZ2K2T2ZY2OPGEZZ22ZL82

Filed on: June 15, 2026

Cuprina Holdings regains compliance with NASDAQ listing requirements

Fri, 12 Jun 2026 09:00:20 -0400

Cuprina Holdings (Cayman) Limited (NASDAQ: CUPR) announced it has regained compliance with NASDAQ Capital Markets listing requirements as of June 11, 2026.

The biomedical company had previously failed to meet the minimum bid price requirement under Listing Rule 5550(a)(2), with securities closing below $1.00 per share for 30 consecutive business days. The company had also failed to regain compliance within the required 180-day period outlined in Listing Rule 5810(c)(3)(a).

On May 29, 2026, Cuprina received a Staff Delisting Determinations Letter from NASDAQ and subsequently appealed the decision by requesting a hearing before the NASDAQ Hearing Panel under Listing Rule 5815.

NASDAQ Listing Qualifications

Cuprina Holdings regains compliance with NASDAQ listing requirements

Fri, 12 Jun 2026 09:00:20 -0400

Cuprina Holdings (Cayman) Limited (NASDAQ: CUPR) announced it has regained compliance with NASDAQ Capital Markets listing requirements as of June 11, 2026.

NASDAQ Listing Qualifications

Form 6-K Cuprina Holdings (Cayman For: Jun 12

Fri, 12 Jun 2026 09:00:00 -0400

si-local-file:///var/storage/secattach/20260612/26638722.html

Form 6-K Cuprina Holdings (Cayman For: Jun 12

Fri, 12 Jun 2026 09:00:00 -0400

si-local-file:///var/storage/secattach/20260612/26638722.html

Cuprina Holdings (Cayman) Limited Regains Compliance with Nasdaq Listing Requirements

Fri, 12 Jun 2026 09:00:00 -0400

SINGAPORE, June 12, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals sectors, today announced that on June 11, 2026 it has regained compliance with the Nasdaq Capital Markets Listing Requirements.

As previously disclosed on May 29, 2026, the Company received a Staff Delisting Determinations Letter (the “Staff Determination”) indicating that the Company’s securities had closed below $1.00 per share for 30 consecutive business days, failing to meet the minimum bid price requirement

Cuprina Holdings (Cayman) Limited Regains Compliance with Nasdaq Listing Requirements

Fri, 12 Jun 2026 09:00:00 -0400

Cuprina Holdings (Cayman) Limited Regains Compliance with Nasdaq Listing Requirements

Fri, 12 Jun 2026 09:00:00 -0400

Cuprina Holdings (Cayman) Limited Regains Compliance with Nasdaq Listing Requirements

Fri, 12 Jun 2026 09:00:00 -0400

Cuprina Holdings completes reverse stock split amid nasdaq delisting threat

Fri, 29 May 2026 12:55:14 -0400

Cuprina Holdings (Cayman) Limited (NASDAQ: CUPR) completed a reverse stock split on May 27, 2026, and requested a hearing before the Nasdaq Hearings Panel to maintain its listing status, according to a company statement.

The biomedical company received a staff determination letter from Nasdaq on May 27, 2026, notifying it that its securities would be scheduled for delisting due to failure to meet the minimum bid price requirement of $1.00 per share for continued listing on The Nasdaq Capital Market.

Nasdaq initially notified Cuprina on November 26, 2025, that the company was not in compliance with the minimum bid price requirement based

Cuprina Holdings completes reverse stock split amid nasdaq delisting threat

Fri, 29 May 2026 12:55:14 -0400

Nasdaq initially notified Cuprina on November 26, 2025, that the company was not in compliance with the minimum bid price requirement based

Cuprina Holdings completes reverse stock split amid nasdaq delisting threat

Fri, 29 May 2026 12:55:14 -0400

Nasdaq initially notified Cuprina on November 26, 2025, that the company was not in compliance with the minimum bid price requirement based

Cuprina Holdings completes reverse stock split amid nasdaq delisting threat

Fri, 29 May 2026 12:55:14 -0400

Nasdaq initially notified Cuprina on November 26, 2025, that the company was not in compliance with the minimum bid price requirement based

Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain Listing